Impact of COVID-19 lockdown on patients with idiopathic intracranial hypertension in Spain

• Published in: Revista de neurologiá 2023-01, Vol.76 (2), p.47
• Main Authors: Carazo-Barrios, L, Gallardo-Tur, A, Aguilar-Monge, A, Heras-González, M L, Sempere-Fernández, J F, Hamad-Cueto, O, Heras-Pérez, J A, de la Cruz-Cosme, C
• Format: Article
• Language: eng ; spa
• Subjects: Anxiety - epidemiology; Anxiety - etiology; Communicable Disease Control; COVID-19 - epidemiology; COVID-19 - psychology; Cross-Sectional Studies; Depression - epidemiology; Depression - psychology; Diplopia; Dizziness; Female; Headache - epidemiology; Headache - etiology; Humans; Pandemics; Pseudotumor Cerebri - epidemiology; Quality of Life; Spain - epidemiology
• ISSN: 1576-6578; 1576-6578
• DOI: 10.33588/rn.7602.2022131

The nationwide lockdown implemented in Spain in March 2020 in response to the 2019 coronavirus disease pandemic (COVID-19) could have had an effect on the clinical situation, disease management and access to care in patients with idiopathic intracranial hypertension. A cross-sectional observational study was conducted by means of an online survey. The frequency and impact of headache, visual symptoms, dizziness, cognitive symptoms, diplopia, anxiety and depression on patients' quality of life were recorded. Disease treatment and delays experienced in accessing care were recorded. Participants were grouped according to the time elapsed since diagnosis. A total of 112 patients participated in the study (103 women). The average time since disease onset was 6.25 years. Headache, anxiety and depression were responsible for considerable impact in the period prior to lockdown. The impact of headache was not aggravated during lockdown, but anxiety and depression did become significantly worse. Recently diagnosed participants reported higher rates of anxiety, depression, dizziness and diplopia; chronically diagnosed participants reported a higher frequency of cognitive symptoms. The clinical situation of the participants deteriorated during lockdown, although the differences were smaller than previously thought. This was probably because the baseline situation was more severe than expected. Further studies are needed to clarify the medium and long-term impact of the COVID-19 pandemic on patients with idiopathic intracranial hypertension.